Because benzodianzepines and other anxiolytics are among the most widely prescribed of all medications, anxiolytic misuse, abuse, and physiological dependence has been of increasing concern. Drug discrimination procedures can provide highly selective behavioral measures of CNS activity which may be analogous to human subjective drug effects. This project will use drug discrimination procidures in baboons and rats to provide new information about behavioural and pharmacological mechanisms of anxiolytic drug action. Four sets of studies will be conducted over a three-year period. One set of studies will begin to explore interrelationships between drug discrimination and drug self-administration by investigating in baboons the effects of a history of drug discrimination training on subsequent drug self-administration and the effects of a history of drug self-administration on subsequent drug discrimination. A second set of studies will use drug discrimination procedures to investigate physiological dependence on benzodiazepines by conducting drug generalization tests with a variety of drigs in benzodiazepine-dependent baboons trained to discriminate administration of a benzodiazepine antegonist. A third set of studies will further investigate molecular mechansims of action of anxiolytics by investigating drig generalization and antagonism with a variety of drugs in baboons trained to discriminate administration of a benzodiazepine inverse agonist. The fourth set of studies will explore central sites mediating the discriminative stimulus effects of benzodiazepines in rats. In addition to contributing scientific information about mechanisms of action of anxiolytic drugs, the research conducted in this project will utimately have clinical relevance in the treatment and prevention of anxiolytic drug abuse and physiological dependence.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA004133-03
Application #
3209331
Study Section
(DABA)
Project Start
1986-04-01
Project End
1989-03-31
Budget Start
1988-04-01
Budget End
1989-03-31
Support Year
3
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Type
Schools of Medicine
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Ator, Nancy A; Atack, John R; Hargreaves, Richard J et al. (2010) Reducing abuse liability of GABAA/benzodiazepine ligands via selective partial agonist efficacy at alpha1 and alpha2/3 subtypes. J Pharmacol Exp Ther 332:4-16
Kohut, Stephen J; Ator, Nancy A (2008) Novel discriminative stimulus effects of TPA023B, subtype-selective gamma-aminobutyric-acid(A)/benzodiazepine modulator: comparisons with zolpidem, lorazepam, and TPA023. Pharmacol Biochem Behav 90:65-73
Weed, Michael R; Wilcox, Kristin M; Ator, Nancy A et al. (2008) Consistent, high-level ethanol consumption in pig-tailed macaques via a multiple-session, limited-intake, oral self-dosing procedure. Alcohol Clin Exp Res 32:942-51
Ator, Nancy A; Griffiths, Roland R; Weerts, Elise M (2005) Self-injection of flunitrazepam alone and in the context of methadone maintenance in baboons. Drug Alcohol Depend 78:113-23
Ator, Nancy A (2005) Contributions of GABAA receptor subtype selectivity to abuse liability and dependence potential of pharmacological treatments for anxiety and sleep disorders. CNS Spectr 10:31-9
Griffiths, Roland R; Bigelow, George E; Ator, Nancy A (2003) Principles of initial experimental drug abuse liability assessment in humans. Drug Alcohol Depend 70:S41-54
Ator, Nancy A (2003) Selectivity in generalization to GABAergic drugs in midazolam-trained baboons. Pharmacol Biochem Behav 75:435-45
Ator, Nancy A; Griffiths, Roland R (2003) Principles of drug abuse liability assessment in laboratory animals. Drug Alcohol Depend 70:S55-72
Ator, Nancy A (2002) Relation between discriminative and reinforcing effects of midazolam, pentobarbital, chlordiazepoxide, zolpidem, and imidazenil in baboons. Psychopharmacology (Berl) 163:477-87
Kaminski, B J; Ator, N A (2001) Behavioral and pharmacological variables affecting risky choice in rats. J Exp Anal Behav 75:275-97

Showing the most recent 10 out of 28 publications